Latest market price
8.55
-1.13-11.67%
OverviewShort InterestFilings
SLSQT92SELLAS Life Sciences Group, Inc.·NASDAQ
8.55-11.67%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 27, 20268-KCurrent report
Jun 25, 20268-KCurrent report
Jun 18, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 16, 2026S-8Registration of employee benefit securities
Jun 02, 20268-KCurrent report
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
Apr 24, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 20, 2026S-3ASRS-3ASR
Mar 19, 202610-KAnnual report
Mar 19, 20268-KCurrent report
Mar 11, 20268-KCurrent report
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jan 09, 20264Statement of changes in beneficial ownership
#1 / 25 of 220
Page
▼
/ 9